UMIN ID: UMIN000002173
Registered date:14/07/2009
Ion beam therapy with concurrent chemotherapy using Gemcitabine for unresectable pancreatic cancer, Phase I/II study
Basic Information
| Recruitment status | |
|---|---|
| Health condition(s) or Problem(s) studied | pancreatic cancer |
| Date of first enrollment | 2009/07/01 |
| Target sample size | 30 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | Ion beam therapy(proton therapy, carbon-ion therapy) |
Outcome(s)
| Primary Outcome | QOL survival time |
|---|---|
| Secondary Outcome |
Key inclusion & exclusion criteria
| Age minimum | 20years-old |
|---|---|
| Age maximum | 80years-old |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | distal metastases |
Related Information
| Primary Sponsor | Department of Radiology, Hyogo Ion Beam Medical Center |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | None |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Kazuki Terashima |
| Address | Japan |
| Telephone | |
| k.terashima@hibmc.shingu.hyogo.jp | |
| Affiliation | Hyogo Ion Beam Medical Center Department of Radiology |
| scientific contact | |
| Name | Masao Murakami |
| Address | 1-2-1 Kouto, Shingu-cho, Tatsuno, Hyogo Japan |
| Telephone | 0791-58-0100 |
| Affiliation | Hyogo Ion Beam Medical Center Department of Radiology |